Based on the Addus HomeCare Corporation stock forecast from 5 analysts, the average analyst target price for Addus HomeCare Corporation is USD 142.38 over the next 12 months. Addus HomeCare Corporation’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Addus HomeCare Corporation is Bullish , which is based on 9 positive signals and 3 negative signals. At the last closing, Addus HomeCare Corporation’s stock price was USD 97.03. Addus HomeCare Corporation’s stock price has changed by +1.32% over the past week, -16.43% over the past month and -5.11% over the last year.
No recent analyst target price found for Addus HomeCare Corporation
No recent average analyst rating found for Addus HomeCare Corporation
Company Overview Addus HomeCare Corporation
Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health. The Personal Care segment provides non-medical assistance with activities of daily living. This segment offers services that include assistance with bathing, grooming, oral care, feeding and dressing, medication reminders, meal planning and preparation, housekeeping, and transportation services. The Hospice segment provides palliative nursing care, social work, spiritual counseling, homemaker, and bereavement counseling services for people who are terminally ill, as well as related services for their families. The Home Health segment offers skilled nursing and physical, occupational, and speech therapy for the individuals who requires assistance during an illness or after hospitalization. The company's payor clients include federal, state, and local governmental agencies; managed care organizations; commercial insurers; and private individuals. Addus HomeCare Corporation was founded in 1979 and is headquartered in Frisco, Texas. Read Less
Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments:...Read More
Frequently Asked Questions About Addus HomeCare Corporation (ADUS) Stock
Based on ratings from 5 analysts Addus HomeCare Corporation's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Bullish . The stock has 8 buy, sell and hold ratings.
Unfortunately we do not have enough data on ADUS's stock to indicate if its a good dividend stock.
Based on targets from 5 analysts, the average taret price for ADUS is USD 142.38 over the next 12 months. The maximum analyst target price is USD 150 while the minimum anlayst target price is USD 129.
ADUS stock's Price/Earning ratio is 22.64.
Our analysis grades ADUS stock's Price / Earning ratio at C-. This means that ADUS stock's Price/Earning ratio is above 29% of the stocks in the Medical Care Facilities sector in the NSD exchange.
Based on this ADUS may be undervalued for its sector.
The last closing price of ADUS's stock was USD 97.03.
The most recent market capitalization for ADUS is USD 1.74B.
Based on targets from 5 analysts, the average taret price for ADUS is projected at USD 142.38 over the next 12 months.
This means that ADUS's stock price may go up by +46.73% over the next 12 months.
We can't find any ETFs which contains Addus HomeCare Corporation's stock.
As per our most recent records Addus HomeCare Corporation has 0 Employees.
Addus HomeCare Corporation's registered address is 6303 Cowboys Way, Frisco, TX, United States, 75034.
You can get more information about it from Addus HomeCare Corporation's website at https://www.addus.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Low volatility
The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.
Superior risk adjusted returns
This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
Superior return on assets
The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.
Superior capital utilization
The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.
High market capitalization
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
Superior Earnings Growth
This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.
Superior return on equity
The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.
What not to like
Overpriced on cashflow basis
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Low Revenue Growth
This stock has shown below median revenue growth in the previous 5 years compared to its sector
Overpriced on free cash flow basis
The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Frequently Asked Questions About Addus HomeCare Corporation (ADUS) Stock
Based on ratings from 5 analysts Addus HomeCare Corporation's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Bullish . The stock has 8 buy, sell and hold ratings.
Unfortunately we do not have enough data on ADUS's stock to indicate if its a good dividend stock.
Based on targets from 5 analysts, the average taret price for ADUS is USD 142.38 over the next 12 months. The maximum analyst target price is USD 150 while the minimum anlayst target price is USD 129.
ADUS stock's Price/Earning ratio is 22.64.
Our analysis grades ADUS stock's Price / Earning ratio at C-. This means that ADUS stock's Price/Earning ratio is above 29% of the stocks in the Medical Care Facilities sector in the NSD exchange.
Based on this ADUS may be undervalued for its sector.
The last closing price of ADUS's stock was USD 97.03.
The most recent market capitalization for ADUS is USD 1.74B.
Based on targets from 5 analysts, the average taret price for ADUS is projected at USD 142.38 over the next 12 months.
This means that ADUS's stock price may go up by +46.73% over the next 12 months.
We can't find any ETFs which contains Addus HomeCare Corporation's stock.
As per our most recent records Addus HomeCare Corporation has 0 Employees.
Addus HomeCare Corporation's registered address is 6303 Cowboys Way, Frisco, TX, United States, 75034.
You can get more information about it from Addus HomeCare Corporation's website at https://www.addus.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for ADUS !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
